Health
A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability – News-Medical.Net
Researchers tested the vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern…
Researchers tested a vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern and the original virus strain.
The emergence of several new mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to concerns about increased transmissibility of the virus and the ability of vaccines to protect against them. Some studies point to lower efficacy of vaccines to the new strains compared to…
-
Noosa News22 hours agoQld nurses poised to strike deal with Crisafulli government
-
General17 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Noosa News14 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
General20 hours agoUS CDC boss Susan Monarez refuses to quit, defying Trump’s White House